Online citations, reference lists, and bibliographies.
← Back to Search

Supportive Care Treatment Guidelines: Value, Limitations, And Opportunities.

D. Peterson, R. Bensadoun, R. Lalla, D. Mcguire
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Evidence-based guidelines in clinical oncology practice are now prominent, with emphasis on clinical, health outcome and economic perspectives. Given the complexity of cancer management, a multidisciplinary approach is essential. Evidence-based guidelines to address supportive cancer care have merged expert opinion, systematic evaluation of clinical and research data, and meta-analyses of clinical trials. Production of supportive care guidelines by the interdisciplinary team is dependent on sufficient high-quality research studies. Once published, it is essential they be customized at institutional and national levels. Implementation in clinical practice is perhaps the greatest challenge. Optimal management occurs through integration of country-specific issues, including care access, healthcare resources, information technology, and national coordination of healthcare practices. The purpose of this article is to: (1) provide an overview of interdisciplinary cancer management using evidence-based guidelines; (2) delineate the theory and practice of guideline dissemination, utilization and outcome assessment; and (3) recommend future research strategies to maximize guidelines use in clinical practice.
This paper references
10.1185/030079905X46313
Optimising antiemetic therapy: what are the problems and how can they be overcome?
M. Aapro (2005)
10.1007/s00520-003-0553-6
Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions
F. Roila (2003)
10.1002/cncr.25109
Cancer Quality‐ASSIST supportive oncology quality indicator set
S. Dy (2010)
10.1002/cncr.20163
Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis
E. Rubenstein (2004)
10.1007/s00520-007-0246-7
Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care
M. Aapro (2007)
10.1007/s00520-006-0051-8
The role of basic oral care and good clinical practice principles in the management of oral mucositis
D. McGuire (2006)
10.1093/JNCIMONOGRAPHS/LGM005
Symptom burden: multiple symptoms and their impact as patient-reported outcomes.
C. Cleeland (2007)
10.1053/J.SONCN.2003.10.010
Evidence-based guidelines for managing mucositis.
D. Mcguire (2004)
10.1200/JCO.2004.06.157
International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument.
J. Burgers (2004)
10.1016/J.RADONC.2005.07.002
Evidence-based recommendations for the use of antiemetics in radiotherapy.
E. Maranzano (2005)
10.1097/CCO.0b013e32833a9fab
Oral mucositis: the new paradigms
D. Peterson (2010)
10.1684/BDC.2008.0677
Standards, Options : Recommandations 2008Prise en charge thérapeutique du patient atteint d’une tumeur maligne des glandes salivaires (lymphomes, sarcomes et mélanomes exclus), rapport abrégé
R. Bensadoun (2008)
The timing of chemotherapy-induced neutropenia and its clinical and economic impact.
H. Ozer (2006)
10.2307/3104547
Diffusion of Innovations
E. M. Rogers (1962)
10.1093/JNCIMONOGRAPHS/LGM003
Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer.
C. Miaskowski (2007)
10.1002/cncr.22484
Updated clinical practice guidelines for the prevention and treatment of mucositis
D. Keefe (2007)
10.1097/PPO.0b13e3181f289f7
Standards for palliative care delivery in oncology settings.
S. Zafar (2010)
NCCN Practice Guidelines for Cancer-Related Fatigue.
V. Mock (2000)
10.1007/s00520-004-0742-y
New directions in supportive care
S. Grunberg (2004)
10.1038/sj.bjc.6601091
Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002)
B. Raynard (2003)
10.1200/JCO.2008.26.15_SUPPL.15087
Treatment-related toxicity and supportive care in metastatic colorectal cancer.
S. Zafar (2010)
10.1007/s00520-006-0060-7
Promulgation of guidelines for mucositis management: educating health care professionals and patients
D. McGuire (2006)
10.1093/QJMED/HCI114
Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study.
C. Mclaughlin (2005)
10.1200/JCO.1998.16.2.771
Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
M. J. Nolte (1998)
10.1016/S0924-8579(00)00240-5
Multinational cooperation in trials and guidelines dealing with febrile neutropenia.
R. Feld (2000)
10.1007/s00520-004-0702-6
Antiemetics in children receiving chemotherapy
F. Roila (2004)
10.1093/annonc/mdr391
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
D. Peterson (2011)
10.1200/JCO.2008.17.2627
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
M. Hensley (2009)
10.1007/s00520-010-0994-7
Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009
K. Jordan (2010)
10.1007/s00520-006-0054-5
Alimentary mucositis: putting the guidelines into practice
M. Brennan (2006)
10.1007/s00520-004-0629-y
Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer
P. Glare (2004)



This paper is referenced by
10.4172/1948-5956.1000153
A Specific Mistletoe Preparation (Iscador-Qu ® ) in Colorectal Cancer (CRC) Patients: More than Just Supportive Care?
Zaenker Ks (2012)
10.4301/S1807-17752014000300003
THE CASE OF INCA´S NATIONAL TUMOR BANK MANAGEMENT SYSTEM IN BRAZIL
A. Gonçalves (2014)
Outsized Treatment Effects of High Potency Polymerized Cross-Linked Sucralfate (ProThelial) for Oral and Gastrointestinal Chemoradiation Mucositis The Level of Evidence and Implication for National Cancer Center Network Category 2A Recommendations
R. Mccullough (2018)
10.1016/S1470-2045(12)70380-7
Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.
S. Payne (2012)
10.1002/pbc.25915
Chemotherapy‐Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group
P. Patel (2016)
10.1007/s00520-013-1924-2
The MASCC/ISOO Mucositis Guidelines: dissemination and clinical impact
R. Lalla (2013)
10.1111/odi.12167
Oral mucosal injury in oncology patients: perspectives on maturation of a field.
D. Peterson (2015)
10.1007/s00520-018-4099-z
Patterns of oral and dental care education and utilization in head and neck cancer patients
J. Epstein (2018)
10.1007/s10072-012-0945-9
Is there a role for neurologist in an oncological home care team?
G. Porzio (2012)
10.1002/9781119121039.ch13
13. Head and Neck Cancer
Facs Steven M. Roser Dmd (2015)
10.1186/s12904-019-0436-3
Examining constipation assessment and management of patients with advanced cancer receiving specialist palliative care: a multi-site retrospective case note review of clinical practice
S. McIlfatrick (2019)
Semantic Scholar Logo Some data provided by SemanticScholar